3-methoxytyramine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hallberg, A; Nilsson, K; Pileblad, E; Tunek, A | 1 |
| Bankiewicz, KS; Hsiao, J; Mefford, I; Skirboll, S; Wang, J | 1 |
| Arai, Y; Kinemuchi, H; Kisara, K; Matsumura, T; Sakuma, I; Satoh, N; Tadano, T | 1 |
| Bizière, K; Guillaumin, JM; Kan, JP; Renoux, G; Renoux, M; Steinberg, R | 1 |
| Hashim, A; Lajtha, A; Mason, MF; Reith, ME; Sershen, H | 1 |
| Carlsson, A; Nissbrandt, H; Pileblad, E | 1 |
| Cosi, C; Marien, M | 1 |
| Abe, K; Miyatake, T; Ren, J; Sano, T; Shinohara, T; Taguchi, K; Utsunomiya, I; Wasai, T | 1 |
| Di Paolo, T; Morissette, M | 1 |
| Caramelli, A; Corsini, GU; Pardini, C; Vaglini, F; Viaggi, C | 1 |
| Charlton, CG; King, J; Mackey, V; Muthian, G | 1 |
| Choi, DK; Kim, IS; Kwon, SJ; Myung, SW; Park, JY; Yoon, SH | 1 |
| Ferger, B; Lechel, A; Oeckl, P; Rudolph, KL; Scheffold, A | 1 |
| Di Paolo, T; Grégoire, L; Morin, N; Morissette, M | 1 |
14 other study(ies) available for 3-methoxytyramine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Investigation of the possible dopaminergic toxicity of 1-methyl-3-phenyl-1,2,3,6-tetrahydropyridine, an isomer to the neurotoxin MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Catecholamines; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; In Vitro Techniques; Isomerism; Limbic System; Magnetic Resonance Spectroscopy; Male; Mice; Mitochondria, Liver; Monoamine Oxidase; MPTP Poisoning; Rats; Rats, Inbred Strains | 1991 |
In vivo changes of catecholamines in hemiparkinsonian monkeys measured by microdialysis.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Catecholamines; Caudate Nucleus; Dialysis; Dopamine; Female; Homovanillic Acid; Hydroxyindoleacetic Acid; Macaca mulatta; Male; Parkinson Disease, Secondary; Putamen | 1990 |
Behavioral and biochemical changes following acute administration of MPTP and MPP+.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Desipramine; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Motor Activity; Nomifensine; Pyridines; Pyridinium Compounds; Selegiline; Serotonin | 1987 |
Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; B-Lymphocytes; Corpus Striatum; Designer Drugs; Ditiocarb; Dopamine; Homovanillic Acid; Immune System; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Male; Metallothionein 3; Mice; Mitogens; Pyridines; Selegiline; T-Lymphocytes | 1989 |
Effect of amphetamine on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dextroamphetamine; Dopamine; Drug Interactions; Homovanillic Acid; Mice; Mice, Inbred BALB C; Pyridines | 1986 |
Biochemical and functional evidence for a marked dopamine releasing action of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (NMPTP) in mouse brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Mice; Motor Activity; Pyridines; Serotonin | 1984 |
Implication of poly (ADP-ribose) polymerase (PARP) in neurodegeneration and brain energy metabolism. Decreases in mouse brain NAD+ and ATP caused by MPTP are prevented by the PARP inhibitor benzamide.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adenosine Triphosphate; Animals; Benzamides; Brain; Corpus Striatum; Dopamine; Dopamine Agents; Frontal Lobe; Male; Mesencephalon; Mice; Mice, Inbred C57BL; NAD; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases | 1999 |
Biochemical and pathological study of endogenous 1-benzyl-1,2,3,4-tetrahydroisoquinoline-induced parkinsonism in the mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Drug Administration Schedule; Homovanillic Acid; Hydroxyindoleacetic Acid; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Parkinson Disease; Parkinson Disease, Secondary; Serotonin; Substantia Nigra; Tetrahydroisoquinolines; Tyrosine 3-Monooxygenase | 2001 |
Effect of estradiol on striatal dopamine activity of female hemiparkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Biogenic Amines; Chromatography, High Pressure Liquid; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Enkephalins; Estradiol; Estrogens; Female; In Situ Hybridization; Iodine Radioisotopes; Macaca fascicularis; Ovariectomy; Parkinsonian Disorders; Protein Precursors; RNA, Messenger | 2009 |
MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 1-Methyl-4-phenylpyridinium; Animals; Corpus Striatum; Cytochrome P-450 CYP2E1; Dopamine; Homovanillic Acid; Male; Mice; Mice, Knockout; MPTP Poisoning; Nerve Tissue Proteins; Neurons; Parkinsonian Disorders; Prodrugs; Substantia Nigra; Tyrosine 3-Monooxygenase | 2009 |
Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Birth Weight; Corpus Striatum; Disease Models, Animal; Dopamine; Female; Homovanillic Acid; Mice; Mice, Inbred C57BL; Motor Activity; Parkinson Disease; Pregnancy; Prenatal Exposure Delayed Effects; Tyrosine 3-Monooxygenase | 2010 |
Simultaneous measurement of serotonin, dopamine and their metabolites in mouse brain extracts by high-performance liquid chromatography with mass spectrometry following derivatization with ethyl chloroformate.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Chromatography, High Pressure Liquid; Dopamine; Formic Acid Esters; Homovanillic Acid; Male; Mass Spectrometry; Mice; Mice, Inbred C57BL; Neurotoxins; Serotonin | 2013 |
Substantial telomere shortening in the substantia nigra of telomerase-deficient mice does not increase susceptibility to MPTP-induced dopamine depletion.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striatum; Dopamine; Dopamine Agents; Homovanillic Acid; Male; Metallothionein 3; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Neurons; Parkinsonian Disorders; Substantia Nigra; Telomerase; Telomere Shortening; Tyrosine 3-Monooxygenase | 2014 |
Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Brain; Disease Models, Animal; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Drug Combinations; Dyskinesia, Drug-Induced; Excitatory Amino Acid Antagonists; Female; Homovanillic Acid; Levodopa; Macaca fascicularis; Ovariectomy; Parkinsonian Disorders; Protein Binding; Pyridines; Serotonin | 2015 |